glp 1 deaths GLP-1 receptor agonists and risk of suicide or suicide attempts – A nationwide cohort and self-controlled case series study Top GLP-1 Agonists Balance Weight

Intraislet production of GLP-1 by activation of prohormone convertase 1/3 in pancreatic -cells in mouse models of -cell regeneration

2025;264:e240259

The pharmacy benefit manager Prime Therapeutics published an analysis last summer that highlights this ongoing challenge with respect to the real-world effectiveness over time of the GLP-1 drugs used to treat obesity: Most overweight or obese patients without diabetes stop treatment within the first few years

For example, gastric inhibitory peptide (GIP), an incretin hormone discovered a decade before GLP-1 (72), has been a major target for developing newer therapies for diabetes and/or obesity

Chest pain, shortness of breath, or rapid heart rate : which could indicate cardiovascular complications Severe weakness or inability to perform normal activities : suggesting possible electrolyte imbalances or other serious conditions You should also schedule a non-urgent appointment if you notice unintentional excessive weight loss (more than 23 pounds per week consistently), difficulty maintaining adequate nutrition , or new symptoms such as cold intolerance, hair loss, or mood changes that might suggest thyroid dysfunction or other endocrine issues